Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients

CONCLUSIONS: CRS+HIPEC improves survival for AOC patients with acceptable safety at experienced high-volume centers. Stringent patient selection and complete CRS are key factors for better survival.PMID:34258265 | PMC:PMC8245244 | DOI:10.1155/2021/5533134

Source: Biomed Res - July 14, 2021 Category: Research Authors: Jue Zhang Xin-Bao Li Zhong-He Ji Ru Ma Wen-Pei Bai Yan Li Source Type: research